Insomnia in patients with schizophrenia: current understanding and treatment options
Department of Psychiatry; Implementation Science and Practice Advances Research Center; Graduate School of Biomedical Sciences
Mental and Social Health | Mental Disorders | Neuroscience and Neurobiology
In patients with schizophrenia, insomnia is a common yet often overlooked comorbidity. With sleep disturbances inextricably linked to increased severity of schizophrenia and worsening clinical outcomes, insomnia is an important therapeutic target within this patient population. Thus, through a review of the current literature, this paper reiterates the important etiological link between these two conditions, while evaluating the safety, efficacy, and limitations of current therapeutic options for the treatment of comorbid insomnia in schizophrenia. Despite the continued use of benzodiazepine receptor agonists (BZRAs) for insomnia, the use of other therapies such as Cognitive Behavioral Therapy for Insomnia (CBT-I) and suvorexant warrants increased consideration. More large-scale clinical trials are needed to assess the efficacy of such therapeutic options in the schizophrenia patient population.
Comorbidity, Insomnia, Pharmacotherapy, Psychosis, Psychotherapy, Schizophrenia
DOI of Published Version
Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jun 8;92:235-242. doi: 10.1016/j.pnpbp.2019.01.016. Epub 2019 Jan 29. Link to article on publisher's site
Progress in neuro-psychopharmacology and biological psychiatry
Robertson, Ian; Cheung, Amy; and Fan, Xiaoduo, "Insomnia in patients with schizophrenia: current understanding and treatment options" (2019). Psychiatry Publications and Presentations. 884.